- Associate Professor, Department of Internal Medicine (Digestive Diseases), Yale School of Medicine, Yale University
Dr. David N. Assis is an Associate Professor of Medicine in the Section of Digestive Diseases at Yale School of Medicine and a hepatologist with expertise in autoimmune liver diseases — including Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis — as well as Cystic Fibrosis.
Dr. Assis conducts clinical and translational research on these disorders with a focus on biomarker development and disease modeling, including the use of bile-derived organoids. He has also led work on drug repurposing, specifically investigating fenofibrate as a treatment for cholestatic liver diseases and studying its mechanism of action. He serves as Associate Director of the Clinical and Translational Core of the NIH-funded Yale Liver Center, where he helped develop an extensive biorepository of human samples for translational research.
Dr. Assis is a member of the steering committees for both the International Autoimmune Hepatitis Group and the International Primary Sclerosing Cholangitis Group. He serves as an Associate Editor of the Journal of Hepatology, holds memberships on additional editorial boards, and is a voting member of the FDA’s Gastrointestinal Drugs Advisory Committee (GIDAC).